# MSGN1

## Overview
Mesogenin 1 (MSGN1) is a gene that encodes a basic helix-loop-helix (bHLH) transcription factor, which is crucial for the development of the paraxial presomitic mesoderm (PSM) in vertebrates. The protein product, mesogenin 1, functions as a master regulator in the differentiation of PSM cells, which are precursors to somites and contribute to the formation of skeletal muscle, vertebrae, and dermis. Mesogenin 1 is involved in the Wnt3a signaling pathway and plays a significant role in epithelial-mesenchymal transition (EMT), cell motility, and segmentation processes during embryonic development (Chalamalasetty2014Mesogenin). The gene's expression and function are tightly regulated by interactions with other transcription factors, such as Tbx6, and its dysregulation has been linked to skeletal dysplasia syndromes (Koparir2024Zebrafish; Wittler2007Expression).

## Structure


## Function
Mesogenin 1 (MSGN1) is a transcription factor that plays a pivotal role in the differentiation of paraxial presomitic mesoderm (PSM) cells, which are precursors to somites and contribute to the formation of skeletal muscle, vertebrae, and dermis. MSGN1 functions as a master regulator by activating transcriptional programs that define PSM identity, epithelial-mesenchymal transition (EMT), motility, and segmentation (Chalamalasetty2014Mesogenin). It is specifically expressed in the mesenchymal cells of the PSM and is involved in the Wnt3a signaling pathway, which regulates EMT and cell movement during gastrulation and axis extension (Chalamalasetty2014Mesogenin).

MSGN1 directly activates EMT pathway genes, including Snai1, and other genes involved in EMT regulation such as Zeb2, Foxc1, and Notch1, promoting a motile mesenchymal state in PSM cells (Chalamalasetty2014Mesogenin). It binds to a unique E-box sequence, distinct from other bHLH transcription factors, and its binding sites are often clustered with those of other EMT transcription factors in transcriptional enhancers (Chalamalasetty2014Mesogenin). MSGN1 is essential for initiating mesodermal progenitor markers and regulating mesoderm differentiation and morphogenesis (Chalamalasetty2014Mesogenin).

## Clinical Significance
Mutations in the MSGN1 gene have been implicated in a novel skeletal dysplasia syndrome. A specific homozygous missense variant, c.374G > T, p.(Arg125Leu), has been identified as potentially pathogenic, leading to skeletal abnormalities such as short stature, mesomelic shortening of the arms, and synostosis of the humero-radial and radio-ulnar joints. This variant is thought to cause a gain-of-function effect, resulting in increased Mesogenin1 activity, which disrupts normal skeletal development (Koparir2024Zebrafish).

The gain-of-function mutation in MSGN1 affects the expression of T-box transcription factors like tbxt and tbx6, which are crucial for mesoderm formation and axial development. This dysregulation is associated with ectopic expression of bmp2a, a direct MSGN1 target, contributing to skeletal anomalies (Koparir2024Zebrafish). In zebrafish models, elevated msgn1 activity has been shown to disrupt Delta-Notch signaling, affecting somite, paraxial mesoderm, and notochord development, which are critical for proper skeletal formation (Koparir2024Zebrafish).

The study of MSGN1 mutations provides insights into the molecular pathogenesis of skeletal dysplasia and highlights the importance of regulated MSGN1 activity in development (Koparir2024Zebrafish). Further research is needed to confirm the link between MSGN1 gain-of-function and the observed syndrome.

## Interactions
Mesogenin 1 (MSGN1) is a transcription factor that plays a crucial role in the differentiation of the paraxial presomitic mesoderm (PSM) by interacting with various proteins and nucleic acids. MSGN1 is known to interact with the Wnt signaling pathway, acting downstream of Wnt3a to regulate the expression of genes involved in epithelial-mesenchymal transition (EMT) and cell motility. It directly activates Snai1 and other EMT-related genes, suggesting a feed-forward mechanism that ensures the activation of EMT and motility programs in PSM cells (Chalamalasetty2014Mesogenin).

MSGN1 also interacts with T-box transcription factors, particularly Tbx6, which is essential for its expression and function in PSM differentiation. The expression of MSGN1 is regulated by the synergistic action of Wnt signaling and Tbx6, with Tbx6 directly binding to the MSGN1 promoter (Wittler2007Expression). This interaction places MSGN1 downstream of Wnt3a and Tbx6 in the regulatory hierarchy controlling PSM development.

In addition to its interactions with proteins, MSGN1 binds to specific E-box sequences in the regulatory regions of its target genes, which include Tbx6, Pdgfra, and Snai1. These interactions are crucial for the transcriptional activation of genes that drive PSM differentiation and mesodermal development (Chalamalasetty2014Mesogenin).


## References


[1. (Wittler2007Expression) Lars Wittler, Eun‐ha Shin, Phillip Grote, Andreas Kispert, Anja Beckers, Achim Gossler, Martin Werber, and Bernhard G Herrmann. Expression of msgn1 in the presomitic mesoderm is controlled by synergism of wnt signalling and tbx6. EMBO reports, 8(8):784–789, July 2007. URL: http://dx.doi.org/10.1038/sj.embor.7401030, doi:10.1038/sj.embor.7401030. This article has 85 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.embor.7401030)

[2. (Chalamalasetty2014Mesogenin) Ravindra B. Chalamalasetty, Robert J. Garriock, William C. Dunty, Mark W. Kennedy, Parthav Jailwala, Han Si, and Terry P. Yamaguchi. Mesogenin 1 is a master regulator of paraxial presomitic mesoderm differentiation. Development, 141(22):4285–4297, November 2014. URL: http://dx.doi.org/10.1242/dev.110908, doi:10.1242/dev.110908. This article has 97 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.110908)

[3. (Koparir2024Zebrafish) Asuman Koparir, Caroline Lekszas, Kemal Keseroglu, Thalia Rose, Lena Rappl, Aboulfazl Rad, Reza Maroofian, Nakul Narendran, Atefeh Hasanzadeh, Ehsan Ghayoor Karimiani, Felix Boschann, Uwe Kornak, Eva Klopocki, Ertuğrul M. Özbudak, Barbara Vona, Thomas Haaf, and Daniel Liedtke. Zebrafish as a model to investigate a biallelic gain-of-function variant in msgn1, associated with a novel skeletal dysplasia syndrome. Human Genomics, March 2024. URL: http://dx.doi.org/10.1186/s40246-024-00593-w, doi:10.1186/s40246-024-00593-w. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-024-00593-w)